Studies on anti-inflammatory effects of an injectable copolymer of fatty acids (Ara 3000 beta®) | OMICS International | Abstract

Journal of Osteoarthritis
Open Access

Like us on:


Considering the opinion of the Editorial Board Members, the publisher has decided to merge Journal of Osteoarthritis to International Journal of Clinical Rheumatology. Therefore, all the existing and future readers, authors are hereby requested to visit the International Journal of Clinical Rheumatology now onwards.

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mini Review

Studies on anti-inflammatory effects of an injectable copolymer of fatty acids (Ara 3000 beta®)

Baugé C1,2*, Beck C3, Devaux E3, Ewert G3 and Boumediene K1,2

1Normandie Univ, France

2UNICAEN, EA4652 MILPAT, Caen, France

3Sexmoor Laboratoires, Saint Remy de Provence, France

*Corresponding Author:
Baugé C
Equipe BioConnecT
Université de Caen Normandie, France
Tel: +33 231068218
Fax: +33 231068224
Email: [email protected]

Received date: December 04, 2015 Accepted date: January 15, 2016 Published date: January 27, 2016

Citation:Baugé C, Beck C, Devaux E, Ewert G and Boumediene K (2016) Studies on Anti-inflammatory effects of an Injectable Copolymer of Fatty acids (Ara 3000 beta®). J Ost Arth 1:102. doi: 10.4172/joas.1000102

Copyright: © 2016 Baugé C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Osteoarthritis (OA) is the most common musculoskeletal disease. It is a long-term chronic disease involving the thinning of cartilage in joints which results in bones rubbing together, creating stiffness, pain, and impaired movement. The current control strategy mainly consists in palliative pain treatment, and there are several medicines on the market that alleviate pain and improve function in OA patients. The identification of new therapeutic drugs or procedures could improve the patient quality of life. Recently, the benefice of fatty acids has emerged. In particular, our work published in Journal of Inflammation highlights, by in vitro and in vivo experiments, the anti-inflammatory effects of an injectable copolymer of fatty acid (Ara 3000 beta®) in joints.